P44 Phase 3 clinical trial results of a new combined oral contraceptive with estetrol 15 MG and drospirenone 3 MG

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    2
    Citations
    NaN
    KQI
    []